Sutter's Prices 'Difficult To Justify,' Antitrust Jury Hears
By Bonnie Eslinger ( February 15, 2022, 10:05 PM EST) -- A California federal jury considering a $411 million antitrust class action against Sutter Health heard videotaped testimony Tuesday from a former Sutter vice president who told higher-ups in 2011 that inconsistent patient ratings made it "difficult to justify" the health giant's higher prices....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.